Financial Data and Key Metrics Changes - The company reported consolidated net revenue of $36.3 million, a 6% increase year over year, driven by higher cannabis flower sales in Israel and higher cannabis extract sales in Canada, partially offset by a decrease in cannabis flower sales in Canada [11] - Gross profit and adjusted gross profit in Q3 were $18.3 million, equating to a 50% gross margin, a 19 percentage point improvement from 31% adjusted gross margins in Q3 2024 [11] - Adjusted EBITDA in Q3 was $5.7 million, an improvement of $11.7 million year-over-year, driven by higher gross profit and lower operating expenses [12] Business Line Data and Key Metrics Changes - In Canada, flower supply constraints led to softer flower revenue year over year, but this was offset by strong performance in edibles and significant growth in the vape category [4] - The Spinach brand ended the quarter as the number two cannabis brand in Canada with 4.5% overall market share, ranking fourth in flower with 4.9% share and third in vapes with 7% share [5] - In edibles, Spinach held the number one position with 19.7% market share, and within gummies, it led the market with 22.8% share [6] Market Data and Key Metrics Changes - In Israel, Cronos Group achieved record net revenue, with Peace Naturals being the number one medical cannabis brand, driven by strong demand for flagship strains [8] - The medical patient count in Israel has returned to growth in 2025, up nearly 5% year to date [9] - International market results were lighter this quarter due to shipment timing, with expectations for the second half of 2025 net revenue to be similar to the first half [9] Company Strategy and Development Direction - The company remains focused on delivering top-line growth, margin expansion, and disciplined cost management while strengthening operations for sustainable profitability [4] - The completion of the phase two expansion at GrowCo is expected to improve flower sales in 2026, resolving supply constraints [5] - Cronos Group maintains a strong balance sheet with no debt and $824 million in cash, providing flexibility for growth and innovation [10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's strategy and highlighted the strong performance of core business segments, anticipating continued growth into 2026 [15] - The company is optimistic about the impact of the Groco expansion on revenue and margins, with expectations for improved capacity utilization over time [17][19] Other Important Information - The company launched new products, including limited-edition seasonal offerings and new strains in Israel, to maintain consumer engagement and retail momentum [7][8] - The company is monitoring potential regulatory changes in Germany that could affect future market dynamics [9] Q&A Session Summary Question: Did any sales from Groco expansion occur in Q3, and what is the expected growth magnitude for 2026? - Management indicated that sales from Groco would gradually show up, with a 70% capacity increase on flower expected to impact revenue positively in 2026 [17] Question: Will underlying gross margins improve with the new Groco capacity? - Management confirmed that increased fixed cost absorption from the new facility could lead to improved margins in the future [18] Question: How much did flower supply constraints impact Q3, and what about shipment timing for international markets? - Management acknowledged that flower supply constraints weighed down performance, and shipment timing shifts would normalize, making the second half of the year similar to the first half [20][21]

Core Insights - Safe Harbor Financial, a fintech leader in the cannabis and hemp industries, is participating in the IgniteIt Cannabis Capital and Policy Summit 2025, highlighting the potential impact of federal reforms on capital movement and M&A in the cannabis sector [1][2]. Company Overview - Safe Harbor is a cannabis-exclusive financial platform that has facilitated over $26 billion in cannabis-related transactions across 41 states and territories [3]. - The company offers tailored banking, lending, payments, and business services specifically designed for the cannabis industry, emphasizing compliance and support for operators [3]. Industry Context - The panel discussion at the summit will focus on how federal reforms, such as rescheduling and expanded banking access, could reshape the fragmented cannabis marketplace and unlock capital for consolidation [2]. - The event will gather key stakeholders, including government officials and industry leaders, to discuss the intersection of federal regulation and access to capital in the evolving legal landscape of cannabis [2].

Core Points - Auxly Cannabis Group Inc. will report its earnings results for the third quarter and nine months ended September 30, 2025, on November 13, 2025, before the financial markets open [1] - The company's regulatory filing, press release, and shareholder letter will be accessible on its website [2] - Auxly aims to be a global leader in quality cannabis products, focusing on helping consumers live happier lives through trusted cannabis offerings [2][3] Financial Updates - Auxly recently repaid a $5 million inventory loan, indicating a positive step in managing its financial obligations [4] Events and Presentations - Auxly is scheduled to present at the Planet MicroCap Showcase in Toronto, highlighting its engagement with investors and the market [5]

Core Insights - TerrAscend Corp reported net revenue of $65.1 million for Q3 2025, showing stability compared to $65.0 million in Q2 2025 and $65.2 million in Q3 2024 [6][7][10] - The gross profit margin improved to 52.1%, up from 51.1% in Q2 2025 and 51.0% in Q3 2024, indicating enhanced operational efficiency [7][12] - The company achieved its 13th consecutive quarter of positive cash flow from continuing operations and 9th consecutive quarter of positive free cash flow, with net cash provided from continuing operations at $7.1 million [4][11][16] Financial Performance - GAAP net loss from continuing operations was $9.9 million, compared to a loss of $6.4 million in Q2 2025 and $15.8 million in Q3 2024 [7][13] - EBITDA from continuing operations was $14.3 million, down from $15.9 million in Q2 2025 but up from $9.7 million in Q3 2024 [7][14] - Adjusted EBITDA from continuing operations was $17.0 million, with an adjusted EBITDA margin of 26.1%, compared to 24.6% in Q2 2025 and 25.9% in Q3 2024 [7][14] Operational Highlights - The company maintained its leadership position in New Jersey, with four of its six stores ranking among the top ten in Pennsylvania and a 14.8% revenue increase in Maryland year-over-year [4][11] - The Apothecarium store in Phillipsburg was the top store in New Jersey, and the launch of a new preroll assortment led to a 32% increase in category sales [11] - The company is on track to exit the Michigan market by year-end 2025, with plans to divest substantially all Michigan assets [5][11] Strategic Developments - TerrAscend completed a $79 million non-dilutive refinancing of existing debt and has an additional uncommitted term loan facility of up to $35 million for strategic M&A [11][17] - The Board of Directors authorized a normal course issuer bid to repurchase up to $10 million of the company's common shares over a 12-month period [11] - Cash and cash equivalents stood at $36.6 million as of September 30, 2025, reflecting a strong balance sheet with no material debt maturities for several years [15][5]

Core Insights - SNDL Inc. reported improved Q3-2025 results with increasing revenues and free cash flow for the quarter [1] - Despite the improvements, noncash impairments led to an overall net loss for the company [1] - The company's stock price has decreased by 22% over the last period [1] Financial Performance - The company experienced an increase in revenues during Q3-2025 [1] - Free cash flow also showed improvement for the quarter [1] - Noncash impairments negatively impacted the overall financial results, resulting in a net loss [1] Stock Market Reaction - SNDL's stock price has declined by 22% recently, indicating market concerns despite the positive revenue and cash flow trends [1]

Core Insights - Cronos Group Inc. achieved record levels of consolidated net revenue, gross profit, and Adjusted EBITDA in Q3 2025, with net revenue increasing by 9% quarter-over-quarter and 6% year-over-year [1][2] - The company reported record-high net revenue in Israel, where its PEACE NATURALS brand remains the number one cannabis brand [1][2] - Cronos Group maintains a strong balance sheet with $824 million in total cash and cash equivalents and short-term investments [1][3] Financial Performance - Net revenue for Q3 2025 was $36.3 million, an increase of $2.1 million from Q3 2024, primarily driven by higher cannabis flower sales in Israel and cannabis extract sales in Canada [10] - Gross profit for Q3 2025 was $18.3 million, up $14.7 million from Q3 2024, attributed to lower inventory step-up costs and higher average sales prices [10][7] - Adjusted EBITDA improved to $5.7 million in Q3 2025, an increase of $11.7 million from Q3 2024, driven by higher gross profit and lower operating expenses [10][7] Market Position - The Spinach brand ended Q3 2025 as the second most popular brand in Canada, holding a 4.5% total market share, and ranked 1 in edibles with a 19.7% market share [11][12] - PEACE NATURALS continues to be the top-performing brand in Israel, achieving record net revenue and sales volume in Q3 2025 [15][16] - International results outside of Israel were modest due to shipment timing, with expectations for second-half performance to align closely with the first half [16] Brand and Product Updates - The Spinach brand launched new products, including SOURZ by Spinach Fully Blasted gummies and limited-edition flavors, reinforcing its leadership in innovative cannabis edibles [12] - Cronos Group's expansion of Cronos GrowCo is complete, with sales from the expansion expected to fuel growth in 2026 [17] - The company introduced new strains under the PEACE NATURALS brand in Israel, reflecting its advanced genetic breeding program and cultivation capabilities [15]

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Core Insights - MariMed Inc. reported financial results for Q3 2025, highlighting sequential growth in revenue, adjusted EBITDA, and operating cash flow, driven by wholesale sales and expansion into new markets [2][3] Financial Performance - Revenue for Q3 2025 was $40.8 million, slightly up from $40.6 million in Q3 2024 [3] - GAAP gross margin decreased to 40% from 41% year-over-year, while non-GAAP gross margin also fell to 41% from 43% [3] - The company reported a GAAP net loss of $2.9 million compared to a loss of $1.0 million in Q3 2024, and a non-GAAP net loss of $1.5 million, down from a net income of $0.5 million in the same period last year [3] - Non-GAAP adjusted EBITDA increased to $5.1 million from $4.7 million year-over-year, with an adjusted EBITDA margin of 13% [3] Operational Highlights - The company expanded its distribution of Betty's Eddies™ to Maine and entered into a Managed Services Agreement in Pennsylvania [5][6] - New agreements were established to distribute products in high-growth states like Pennsylvania and New York, with anticipated distribution starting in 2026 [6][10] - The launch of adult-use sales in Delaware contributed to revenue growth, despite facing competition in Illinois [2][5] Cash Flow and Assets - Cash and cash equivalents at the end of Q3 2025 were $6.6 million, down from $7.3 million at the end of 2024 [19] - Total current assets increased to $60.1 million from $53.5 million year-over-year, driven by higher inventory levels [19] - Total liabilities rose to $136.6 million from $129.4 million, with current liabilities also increasing [19] Strategic Initiatives - The company is focused on owning top-selling national cannabis brands and expanding its brand portfolio into new markets [2] - MariMed's management emphasized disciplined cost management and operational efficiencies to improve profitability [2]

Core Insights - Jeremy Szafron has joined Kitco News as an anchor and producer, bringing a wealth of experience in journalism, particularly in finance and current affairs [1][5] Background and Career Development - Jeremy began his journalism career in 2006 at CTV, where he transitioned from entertainment reporting to business reporting, focusing on mining and small-cap companies [2] - He gained recognition for his macro-financial and market trends analysis, becoming a sought-after commentator on CTV Morning Live and CTV News Network [2] - A significant highlight of his career was covering the 2010 Vancouver Olympic Games, which led to the development of an online video news program for PressReader, a digital newsstand with 8,000 editions in 60 languages [3] Digital Media and Industry Impact - In 2012, Jeremy launched The Green Scene Podcast, which quickly attracted over 400,000 subscribers, establishing him as a prominent voice in the cannabis industry [4] - Following this success, he created Investor Scene and Initiate Research, platforms that provide exclusive market insights and deal-flow opportunities in mining and Canadian small-cap sectors [4] Professional Expertise - Jeremy has experience as a market strategist and investor relations consultant for various publicly traded companies across mining, energy, consumer packaged goods (CPG), and technology industries [5] - He holds a BA in Journalism from Concordia University, which has contributed to his diverse career in media and finance [5]

Core Insights - Green Thumb Industries reported third quarter revenue of $291 million, reflecting a 2% year-over-year increase, despite price compression in key markets [4][11] - The company achieved an adjusted EBITDA of $80 million, representing 28% of revenue, and cash flow from operations of $74 million [4][8] - The balance sheet remains strong with cash and cash equivalents totaling $226 million, and no senior credit facility maturities for four years [4][18] Financial Performance - Total revenue for Q3 2025 was $291.4 million, up 1.6% from the previous year [11] - Consumer Packaged Goods revenue increased by 8%, while retail revenue declined by 1% due to price compression in existing markets [11] - Gross profit was $144 million, or 49.4% of revenue, down from 51.4% in the prior year due to price compression [12] Share Repurchase and Capital Allocation - The company has repurchased approximately $107 million of subordinate voting shares since late 2023, reducing total shares outstanding by 13.5 million [5][19] - A new share repurchase program for $50 million was authorized, extending through September 2026 [5][19] Market Expansion and Strategy - The eighth Minnesota RISE Dispensary commenced adult-use sales on October 21, 2025, contributing to the company's growth strategy [3][10] - The company completed a transaction with RYTHM, Inc. to expand THC products beyond dispensaries, enhancing its market position [7] Industry Context - Despite ongoing challenges such as federal reform uncertainty and 280E taxation, cannabis demand continues to rise, positioning it as a fast-growing consumer category [6] - The company remains optimistic about future market share expansion and the establishment of adult-use markets in states like Virginia [11]